Yelak Biru, President and Chief Executive Officer of International Myeloma Foundation, shared a post on X a paper by Susan Bal published in The Lancet Haematology:
“Monumen-TAL progress in the treatment of relapsed multiple myeloma – Ongoing drug development of novel agents and deployment of innovative combinations remains paramount in chasing the elusive cure.”
“Monumen-TAL progress in the treatment of relapsed multiple myeloma”
Author: Susan Bal.
More posts featuring Yelak Biru.